Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (551-560 of 1,833) with videos related to

Pageof 184
Sort By:
Mabs|June 30, 2015
Metal ion interactions with mAbs: Part 1Zephania Kwong Glover, Louisette Basa, Benjamin Moore, et al.
Mabs|June 6, 2015
Structure-guided residence time optimization of a dabigatran reversal agentFelix Schiele, Joanne van Ryn, Tobias Litzenburger, et al.
Mabs|May 21, 2020
Investigation of anomalous charge variant profile reveals discrete pH-dependent conformations and conformation-dependent charge states within the CDR3 loop of a therapeutic mAbWenkui Lan, Joseph J Valente, Andrew Ilott, et al.
Mabs|April 29, 2020
Rapid identification of highly potent human anti-GPCR antagonist monoclonal antibodiesMartin J Scott, Amanda Jowett, Martin Orecchia, et al.
Mabs|May 20, 2020
Biomanufacturing evolution from conventional to intensified processes for productivity improvement: a case studyJianlin Xu, Xuankuo Xu, Chao Huang, et al.
Mabs|May 4, 2021
Targeting cancer homing into the lymph node with a novel anti-CCR7 therapeutic antibody: the paradigm of CLLCarlos Cuesta-Mateos, Raquel Juárez-Sánchez, Tamara Mateu-Albero, et al.
Mabs|September 7, 2021
Ten years in the making: application of CrossMab technology for the development of therapeutic bispecific antibodies and antibody fusion proteinsMarlena Surowka, Wolfgang Schaefer, Christian Klein
Mabs|December 2, 2022
A novel anti-NGF PEGylated Fab' provides analgesia with lower risk of adverse effectsYukari Koya, Hirotsugu Tanaka, Eiji Yoshimi, et al.
Mabs|December 16, 2022
Receptor occupancy assessment and interpretation in terms of quantitative systems pharmacology: nivolumab case studyDmitry Shchelokov, Oleg Demin
Mabs|December 13, 2022
Characterization of the high-affinity anti-CTLA-4 monoclonal antibody JS007 for immune checkpoint therapy of cancerJiawei Guan, Hongchuan Liu, Yan Chai, et al.
Pageof 184

Showing results (551-560 of 1,833) with videos related to

Sort By:
Pageof 184
Mabs|June 30, 2015
Metal ion interactions with mAbs: Part 1Zephania Kwong Glover, Louisette Basa, Benjamin Moore, et al.
Mabs|June 6, 2015
Structure-guided residence time optimization of a dabigatran reversal agentFelix Schiele, Joanne van Ryn, Tobias Litzenburger, et al.
Mabs|May 21, 2020
Investigation of anomalous charge variant profile reveals discrete pH-dependent conformations and conformation-dependent charge states within the CDR3 loop of a therapeutic mAbWenkui Lan, Joseph J Valente, Andrew Ilott, et al.
Mabs|April 29, 2020
Rapid identification of highly potent human anti-GPCR antagonist monoclonal antibodiesMartin J Scott, Amanda Jowett, Martin Orecchia, et al.
Mabs|May 20, 2020
Biomanufacturing evolution from conventional to intensified processes for productivity improvement: a case studyJianlin Xu, Xuankuo Xu, Chao Huang, et al.
Mabs|May 4, 2021
Targeting cancer homing into the lymph node with a novel anti-CCR7 therapeutic antibody: the paradigm of CLLCarlos Cuesta-Mateos, Raquel Juárez-Sánchez, Tamara Mateu-Albero, et al.
Mabs|September 7, 2021
Ten years in the making: application of CrossMab technology for the development of therapeutic bispecific antibodies and antibody fusion proteinsMarlena Surowka, Wolfgang Schaefer, Christian Klein
Mabs|December 2, 2022
A novel anti-NGF PEGylated Fab' provides analgesia with lower risk of adverse effectsYukari Koya, Hirotsugu Tanaka, Eiji Yoshimi, et al.
Mabs|December 16, 2022
Receptor occupancy assessment and interpretation in terms of quantitative systems pharmacology: nivolumab case studyDmitry Shchelokov, Oleg Demin
Mabs|December 13, 2022
Characterization of the high-affinity anti-CTLA-4 monoclonal antibody JS007 for immune checkpoint therapy of cancerJiawei Guan, Hongchuan Liu, Yan Chai, et al.
Pageof 184